Back
Cytokinetics Stock Predictions
Sponsored
CYTK
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
53
CYTK
Cytokinetics
Last Price:
54.71
Seasonality Move:
9.1%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Cytokinetics Stock Forecast
- Over the next 52 weeks, Cytokinetics has on average historically risen by 12.1% based on the past 20 years of stock performance.
- Cytokinetics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Cytokinetics Stock Undervalued?
The current Cytokinetics [CYTK] share price is $54.70. The Score for CYTK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal. - CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Cytokinetics Stock Go Up Next Year?
- Over the next 52 weeks, Cytokinetics has on average historically risen by 12.1% based on the past 20 years of stock performance.
Cytokinetics Stock Rating
Buy
53
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics overpriced?
- Cytokinetics has risen higher in 8 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Cytokinetics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cytokinetics.com
52-Week Data
52-Week High:
110.25
52-Week Low:
30.68
Prediction Charts
Market Cap:
6.46B
Price in USD:
54.70
Volume:
896.05K
Beta:
1.44
Technical Analysis
SMA50:
54.19
SMA100:
55.12
SMA200:
60.40
52-Wk Change:
59.52%
Stock Predictions
-
Is Cytokinetics stock public?
Yes, Cytokinetics is a publicly traded company. -
What is the Cytokinetics stock quote today?
The Cytokinetics stock price is 54.70 USD today. -
How to buy Cytokinetics stock online?
You can buy Cytokinetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-28 | 52.25 | 52.26 | 53.32 | 52.04 |
Oct-29 | 51.92 | 51.51 | 52.24 | 51.19 |
Oct-30 | 50.93 | 51.37 | 52.07 | 50.93 |
Oct-31 | 51.04 | 51.05 | 51.47 | 50.53 |
Nov-1 | 51.61 | 51.82 | 52.37 | 51.02 |
Nov-4 | 51.35 | 51.48 | 52.10 | 50.97 |
Nov-5 | 51.31 | 52.52 | 53.00 | 50.88 |
Nov-6 | 53.99 | 55.50 | 55.68 | 53.19 |
Nov-7 | 54.99 | 55.84 | 57.48 | 54.63 |
Nov-8 | 56.31 | 57.98 | 58.74 | 56.10 |
Nov-11 | 59.31 | 58.62 | 59.39 | 57.80 |
Nov-12 | 58.33 | 56.21 | 58.95 | 56.08 |
Nov-13 | 56.79 | 55.95 | 57.75 | 55.95 |
Nov-14 | 55.74 | 54.70 | 56.31 | 54.56 |
Cytokinetics Earnings
Cytokinetics Earnings Report: Per Share Cytokinetics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cytokinetics Forecast Revenue Growth
Cytokinetics Stock Analysis: Historical quarterly revenues per share for Cytokinetics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $0.11 per share.
* Cytokinetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.